Pablo G. Legorreta, CEO, Chairman of the Board at Royalty Pharma plc (RPRX), bought 460,000 shares at $33.57 ($15.4M) on 2023-05-16, disclosed to the SEC on 2023-05-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.57 | 160,388 | $5.4M | 35.1% |
| 2 | $33.57 | 160,388 | $5.4M | 35.1% |
| 3 | $32.94 | 69,612 | $2.3M | 14.9% |
| 4 | $32.94 | 69,612 | $2.3M | 14.9% |
| Total | $33.38 avg | 460,000 | $15.4M | 100% |
| Filing → |
| RPRX | BUY | 2023-06-13 | $3.0M | — | Filing → |
| RPRX | BUY | 2023-05-24 | $4.8M | — | Filing → |
| RPRX | BUY | 2020-06-22 | $280K | — | Filing → |